RFG
NVO

RFP Financial Group’s Novo Nordisk NVO Stock Holding History

RFP Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-713
Closed -$102K – 561
2024
Q2 		$102K Sell
713
-49
-6% -$6.49K 0.04% 160
2024
Q1 		$97.8K Buy
762
+322
+73% +$38.3K 0.04% 147
2023
Q4 		$45.5K Hold
440
– – 0.02% 206
2023
Q3 		$40K Hold
440
– – 0.02% 217
2023
Q2 		$35.6K Hold
440
– – 0.01% 243
2023
Q1 		$35K Hold
440
– – 0.04% 137
2022
Q4 		$29.8K Buy
+440
New +$25.8K 0.01% 242

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RFP Financial Group's NVO Position: Q3 2024 in Review

RFP Financial Group sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 713 shares — an estimated $102K sold.

RFP Financial Group first reported a position in NVO in Q4 2022 and held it in 7 quarters. The position peaked at $102K in Q2 2024. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • RFP Financial Group reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 713 Novo Nordisk shares in Q3 2024, an estimated $102K.
  • RFP Financial Group first reported a position in Novo Nordisk in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Novo Nordisk position peaked at $102K in Q2 2024.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.